Ubs Asset Management Americas Inc Edgewise Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 272,857 shares of EWTX stock, worth $3.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
272,857
Previous 279,125
2.25%
Holding current value
$3.69 Million
Previous $7.45 Million
19.46%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$203 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$121 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$88.7 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$83.4 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$81.5 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $855M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...